Should you buy BBIO right now? Stockgaide's algorithm rates BBIO as BUY, with a technical score of 80/100. The 50-day average is above the 200-day average, and RSI sits at 48.3. Wall Street's consensus rating is 1.89/5.
The technical setup shows a BUY signal with a score of 80 out of 100. The RSI at 48.3 sits near neutral, while the 50‑day moving average of 77.75 remains above the 200‑day average of 72.87, indicating a prevailing uptrend. However, the MACD histogram is negative at -0.56, hinting at fading momentum. The stock trades within a 52‑week range of 46.81 to 93.42.
Analyst sentiment is strongly positive, with a consensus rating of 1.89 on a scale where 1 equals a strong buy, suggesting the majority view the shares favorably.
Investors should watch whether the price can hold above the 50‑day average, if the MACD histogram turns positive, and any shifts in analyst ratings or price action near the 52‑week highs. This is educational content, not investment advice.
Analyst ratings: 25 Buy · 3 Hold · 0 Sell (1 = Strong Buy, 5 = Strong Sell)
Stockgaide's algorithm currently rates BBIO as BUY, with a technical score of 80 out of 100. This is educational content, not investment advice.
BBIO's 50-day moving average (77.75) is above its 200-day moving average (72.87), which points to a medium-term uptrend.
BBIO has a 14-day RSI of 48.3, which places it in neutral territory (above 70 is overbought, below 30 is oversold).
Wall Street analysts covering BBIO have a consensus rating of 1.89 out of 5 (1 = Strong Buy), meaning they lean Buy — 25 Buy · 3 Hold · 0 Sell.
Price targets, fundamentals deep-dive and an AI-written report — free, no signup.
Analyze BBIO now →